申请人:Nagashima Shinya
公开号:US20100105658A1
公开(公告)日:2010-04-29
[Problems] Provided is a compound which has an antagonistic action on a muscarinic M
3
receptor and is useful as an active ingredient of a prophylactic and/or therapeutic agent for an inflammatory disease such as a chronic obstructive pulmonary disease (COPD), asthma and the like.
[Means for Solving Problems] The present inventors have made studies on a compound having an antagonistic action on the binding of a muscarinic M
3
receptor, and they have found that an aza-bridged-ring compound or a salt thereof has an antagonistic action on the binding of a muscarinic M
3
receptor, thereby completing the present invention. The aza-bridged-ring compound of the present invention has an antagonistic action on the binding of a muscarinic M
3
receptor, and can be used as a prophylactic and/or therapeutic agent for an inflammatory disease such as a chronic obstructive pulmonary disease (COPD), asthma and the like.
【问题】提供了一种具有抗胆碱能M3受体拮抗作用的化合物,可作为预防和/或治疗慢性阻塞性肺疾病(COPD)、哮喘等炎症性疾病的活性成分。
【解决问题的手段】本发明人对具有抗胆碱能M3受体结合作用的化合物进行了研究,发现一种氮杂环桥合环化合物或其盐具有抗胆碱能M3受体结合作用,从而完成了本发明。本发明的氮杂环桥合环化合物具有抗胆碱能M3受体结合作用,并可用作预防和/或治疗慢性阻塞性肺疾病(COPD)、哮喘等炎症性疾病的预防和/或治疗剂。